Sanofi Quote - SAN

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

92.10

Bid

92.00

Ask

92.55

Volume

735,400

92.03 Day's Range 92.70

83.28 52 Week Range 106.14

Market Cap

115.368B

Previous Close

92.31

Open

92.47

Last Trade

92.1

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,526,344

Shares Outstanding

1,252,640,466

Dividend Yield

12.03%

PE Ratio

21.36

Earnings Per Share (EPS)

4.31

Revenue

43.07B

Net Profit

5.4B

Sector

Health & Allied Services,nec

Industry

Pharmaceutical Preparations

Website

www.sanofi.com

Headquarters

Paris, Paris, Fra

Founded

1994

Sanofi is listed in the Health & Allied Services sector of the Euronext with ticker SAN. The last closing price for Sanofi was 92.31 €. Over the last year, Sanofi shares have traded in a share price range of 83.28 € to 106.14 €.

Sanofi currently has 1,252,640,466 shares outstanding. The market capitalization of Sanofi is 115.63 € billion. Sanofi has a price to earnings ratio (PE ratio) of 21.36.

Sanofi: Information concerning the total number of voting rights and shares - October 2024

Sanofi: Information concerning the total number of voting rights and shares - October 2024 Information concerning the total number of voting rights and shares, provided pursuant to article L...

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Octobre 2024

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Octobre 2024 Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II...

Communiqué de presse : La FDA a accepté l’examen de la sBLA pour le Dupixent dans le traitement de l’urticaire chronique spontanée

Communiqué de presse : La FDA a accepté l’examen de la sBLA pour le Dupixent dans le traitement de l’urticaire chronique spontanée La FDA a accepté l’examen de la sBLA pour le Dupixent dans le...

Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria

Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive...

Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria

Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria...

Communiqué de presse : Sarclisa : approbation recommandée par le CHMP dans l’UE pour le traitement du myélome multiple nouvellement diagnostiqué non éligible à une greffe

Communiqué de presse : Sarclisa : approbation recommandée par le CHMP dans l’UE pour le traitement du myélome multiple nouvellement diagnostiqué non éligible à une greffe Sarclisa : approbation...

Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma

Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma Sarclisa recommended for EU approval by the CHMP to treat...

Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma

Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma Recommendation based on IMROZ phase 3 study demonstrating Sarclisa in combination...

Press Release: Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis

Press Release: Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis Dupixent approved in the EU as the first and only medicine for young...

Communiqué de presse : Dupixent, premier et seul médicament approuvé dans l’UE pour le traitement de l’œsophagite à éosinophiles du jeune enfant

Communiqué de presse : Dupixent, premier et seul médicament approuvé dans l’UE pour le traitement de l’œsophagite à éosinophiles du jeune enfant Dupixent, premier et seul médicament approuvé dans...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.66	1.83547103052	90.44	93.42	90.21	1529767	92.27593402	DE
4	-6.45	-6.54490106545	98.55	99.11	90.17	1627423	93.98275752	DE
12	-13	-12.3691722169	105.1	106.14	90.17	1526344	99.25218011	DE
26	2.17	2.41298787946	89.93	106.14	85.94	1508493	96.11208585	DE
52	5.41	6.24062752336	86.69	106.14	83.28	1461770	92.90155275	DE
156	6.51	7.60602874168	85.59	106.66	76.45	1757424	92.52884717	DE
260	7.9	9.38242280285	84.2	106.66	67.65	1953427	89.33966557	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ALKALKALRAY SA	2.16 € (109.71%)	948k
ALEUPEuroplasma	0.115 € (86.99%)	15.44M
ALNEVNeovacs	0.0003 € (50.00%)	225.63M
ALSPWSpineway	0.1191 € (45.60%)	7.98M
RWIRenewi Plc	9.54 € (42.39%)	1.55M
GJAJGroupe Jaj	0.60 € (-43.93%)	300
ALIMOGroupimo	0.189 € (-30.51%)	53
ALDVAlliance Developpement Capital Siic	0.056 € (-24.32%)	62
ATOAtos SE	0.7814 € (-22.86%)	42.95M
MLAATAzorean Tech	0.095 € (-20.83%)	300
ALNEVNeovacs	0.0003 € (50.00%)	225.63M
ALHPIHopium SA	0.0091 € (0.00%)	93.28M
ATOAtos SE	0.7814 € (-22.86%)	42.95M
BCPBanco Comercial Portugues SA	0.4468 € (0.63%)	38.07M
ALDRVDrone Volt	0.0037 € (2.78%)	21.94M

europa7 47 seconds ago

Hashgraph Association to explore five crypto use cases in Qatar
September 20, 2024
https://crypto.news/hashgraph-association-to-explore-five-crypto-use-cases-in-qatar/

"...Over the next twelve months, The Hashgraph Association will lead projects that address these five a

HBARUSD

Money hunt 1 minute ago

E-Trade back online and all numbers updated. It's go time tomorrow and Monday.

ELAB

janice shell 2 minutes ago

Thank you...

janice shell 3 minutes ago

Thank you. I shall try. I've been sleeping, but it hasn't done me that much good.

rooster 3 minutes ago

Absolutely spot on walter… https://x.com/walterkirn/status/1862204087170724060?s=46&t=qLQnO1TjeygtFbhEqQdlmg

excel 4 minutes ago

As Williams tried to get the play off, Bears coach Matt Eberflus didn't call Chicago's last timeout. He said he was conserving it to set up a field-goal attempt.

"The hope was we could re-rack the play, snap it with about 18 seconds left, throw it into field-goal range and call the ti

sam1933 5 minutes ago

a new candlestick forming for the Thanksgiving Day.
Let's start with a GREEN candlestick https://ih.advfn.com/p.php?pid=staticchart&s=COIN%3AHBARUSD&p=0&t=17&width=288&height=147&vol=1&delay=1&min_pre=330&min_after=240

HBARUSD

delerious1 6 minutes ago

yes absolutely....so glad I picked up a bundle of NBRI...and so glad for the updates from all areas....where else could anyone get that sense of security....and........ we get to watch Pro Football while we discuss our Luck LOL

NBRI

rooster 6 minutes ago

https://x.com/onefinejay/status/1861949925547819018?s=46&t=qLQnO1TjeygtFbhEqQdlmg

janice shell 6 minutes ago

No, I did not. Slept all day. Still have the sore throat...

Money hunt 6 minutes ago

So I thought I would try some Dana graphics on ELAB, but I couldn't find any relative to what I was looking for. I kept getting an error saying there is no Dana...
Only Zuul.
Smile folks...It's about time to head to brighter horizons into blue skies$$$

ELAB

OTCShotCaller 6 minutes ago

You NAILED it real good! See my above post....I mention the EXACT same thing among other highly important matters that place CYBL way ahead of the pack!

Best Wishes!

CYBL

rooster 7 minutes ago

https://x.com/realdonaldtrump/status/1862281187600793830?s=46&t=qLQnO1TjeygtFbhEqQdlmg

Tadaaa 8 minutes ago

Yup, Weekly and Monthly, Daily just hit the Golden Cross

HBARUSD

3331 9 minutes ago

Your "guarantee" means absolutely nothing chump.

Penny Hopeful 10 minutes ago

hurry, hurry, hurry
SMME has been such a resounding success that she is at it gain over at Smart Biometric Technologies
Don't mis your opportunity ?????

PATENTS ISSUED -

PRE PRODUCT RELEASE INVESTMENT OPPPORTUNITY

A FUND RAISING ROU

SMME

janice shell 12 minutes ago

As a matter of fact, several of the tickers that had the buy button turned off a few years ago have recently become current and have experienced a price and volume surge.

And which ones would those be? Got some specific examples?

This ticker is no different.

CRGP

MRc2 12 minutes ago

Who let you out. I do hope you had a good Thanksgiving Mr. Crumb. now as for Triller... word is more TT folks headed into the company with Mr. Km coming aboard.. Now are you going to say Sean Kim is a idiot for coming into ILLR . ... Mr. Crumb rumor is a lot of press on its way. Nice try though..

ILLR

ironhammer 15 minutes ago

i agree Del a lot of good things comming

NBRI

MartinLutherKing 16 minutes ago

Suspect tomorrow will be the beginning of a multi day squeeze. I will be going in heavily on this one

ELAB

pennyonfire 16 minutes ago

The Santa Claus rally starts tomorrow

AZRH

Koog 17 minutes ago

Could you possibly be more succinct?

BIEL

OTCShotCaller 17 minutes ago

We've entered "The Rise of The Drone Age" which is rapidly gaining momentum! The Elon Musk & Trump Years mark the rise of the Drone Age, let there be no doubt about it!

Not only are drones required in the new age of global warfare, they have expanded applications like U.S. border sec

CYBL UMAC

delerious1 19 minutes ago

So as we see in the re-cap of the latest develpoments with the Mill and 3 mines....NBRI it would show that things are goin' great....and they're only gettin' better...doin' all right...gettin' good grades....the future's so bright...we gotta wear shades

NBRI

MartinLutherKing 19 minutes ago

$3 News coming tomorrow morning brother stay tuned P/M

RNAZ

	Real-time Prices	Level 2
Dow Jones Indices
Toronto Stock Exchange
Toronto Stock Exchange Venture Exchange
OTCBB
New York Stock Exchange
NASDAQ
American Stock Exchange
OTCMarkets
Canadian Securities Exchange
OPRA
OPRA Indices
Forex

	Real-time Prices	Level 2
Dow Jones Indices
Toronto Stock Exchange
Toronto Stock Exchange Venture Exchange
OTCBB
New York Stock Exchange
NASDAQ
American Stock Exchange
OTCMarkets
Canadian Securities Exchange
OPRA
OPRA Indices
Forex

BLACK FRIDAY

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Sanofi (SAN) Share Price

Sanofi (SAN)

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

About Sanofi

Ask ADVFN Intelligence (AI)

SAN Latest News

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

BLACK FRIDAY

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%